H3K18 lactylation promotes osteogenic differentiation of periodontal ligament stem cells via IGF2BP1/m6A/BMP2
Biochemical Pharmacology · 2026
DOI: 10.1016/j.bcp.2026.117899 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Zhuo Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China. Hauptthemen laut MEDLINE: Periodontal Ligament, Osteogenesis, Stem Cells, Adenosine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
The osteogenic commitment of periodontal ligament-derived stem cells (PDLSCs) represents a critical therapeutic target for managing periodontitis and restoring tissue homeostasis. While lactylation and N6-methyladenosine (m6A) are known to play roles in the osteogenic differentiation of stem cells, the specific molecular mechanisms of these modifications in this regulatory process remain unclear. Pan histone lysine lactylation (Pan-Kla) and H3K18 lactylation (H3K18la) levels were evaluated in maxillary bone of periodontitis model mice and PDLSCs induced to undergo osteogenic differentiation. The levels of lactylation were regulated by Oxamate (a lactate dehydrogenase inhibitor) and sodium lactate (Nala). The regulatory role of lactylation on alveolar bone resorption and osteogenic differentiation of PDLSCs was further investigated. Chromatin Immunoprecipitation (ChIP)-qPCR and RNA-binding protein immunoprecipitation (RIP)-qPCR were analyzed to verify the target gene regulated by H3K18la and m6A. Our data suggested that the Pan-Kla and H3K18la levels were associated with osteogenic differentiation of PDLSCs. High expression of lactylation increased the resorption of alveolar bone and inhibited the osteogenic differentiation of PDLSCs, and reduced lactylation levels showed the opposite regulatory effect. Moreover, ChIP-qPCR data indicated that H3K18la was enriched in IGF2BP1, and high expression of IGF2BP1 significantly promoted the osteogenic differentiation of PDLSCs, and this may be related to the regulation of BMP2 in the m6A dependent way. Taken together, our report highlights the role of osteogenic differentiation of PDLSCs via lactylation and m6A and the significance of H3K18la regulation of IGF2BP1, which may be useful for finding effective therapeutic targets in periodontitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China.
- Department of Stomatology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China. Electronic address: 1600125@tongji.edu.cn.
Zitieren
APA
Wang, Z., Weng, B., Qian, J., & Guo, H. (2026). H3K18 lactylation promotes osteogenic differentiation of periodontal ligament stem cells via IGF2BP1/m6A/BMP2. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.117899
Vancouver
Wang Z, Weng B, Qian J, Guo H. H3K18 lactylation promotes osteogenic differentiation of periodontal ligament stem cells via IGF2BP1/m6A/BMP2. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.117899
BibTeX
@article{Wang2026,
author = {Wang, Zhuo and Weng, Beimiao and Qian, Jing and Guo, Huayan},
title = {H3K18 lactylation promotes osteogenic differentiation of periodontal ligament stem cells via IGF2BP1/m6A/BMP2},
journal = {Biochemical Pharmacology},
year = {2026},
doi = {10.1016/j.bcp.2026.117899}
}
EUVIMED